Cargando…
Serum antinuclear antibodies associate with worse prognosis in AQP4‐positive neuromyelitis optica spectrum disorder
BACKGROUND: Studies have demonstrated that antinuclear antibodies (ANAs) may be correlated with neuromyelitis optica spectrum disorder (NMOSD). However, the conflicting results of studies about the value of ANAs in AQP4 antibody‐positive NMOSD patients need to be further investigated. MATERIAL: Case...
Autores principales: | Fan, Rong, Zhang, Yuefeng, Xu, Yunqi, Tong, Jiayi, Chen, Zhigang, Gu, Meifeng, Fan, Wenkui, Chen, Yong, Peng, Fuhua, Jiang, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821584/ https://www.ncbi.nlm.nih.gov/pubmed/33319460 http://dx.doi.org/10.1002/brb3.1865 |
Ejemplares similares
-
Altered fovea in AQP4-IgG–seropositive neuromyelitis optica spectrum disorders
por: Motamedi, Seyedamirhosein, et al.
Publicado: (2020) -
No association of AQP4 polymorphisms with neuromyelitis optica and multiple sclerosis
por: Yang, Ting-Ting, et al.
Publicado: (2016) -
Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositivepatients in a Chinese population
por: Mao, Zhifeng, et al.
Publicado: (2015) -
Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
por: Palace, Jacqueline, et al.
Publicado: (2019) -
Mirror-Image Lesions in Sequential Relapses of AQP4-Positive Neuromyelitis Optica Spectrum Disorder
por: Muir, Ryan T., et al.
Publicado: (2020)